Search results
Showing 46 to 60 of 98 results for healthcare-associated infections: prevention and control
following outcomes: symptomatic urinary tract infections, urinary tract infection-associated bacteraemia, mortality,...
Evidence-based recommendations on procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay).
NICE has developed a medtech innovation briefing (MIB) on Biopatch for venous or arterial catheter sites .
catheterisation carries a significant risk of symptomatic urinary tract infection, which can lead to more serious complications. Several...
Plus Sutures for preventing surgical site infection (HTG586)
Evidence-based recommendations on Plus Sutures for preventing surgical site infection.
Chronic wounds: advanced wound dressings and antimicrobial dressings (ESMPB2)
Summary of the evidence on advanced wound dressings and antimicrobial dressings for managing chronic wounds to inform local NHS planning and decision-making
QuikRead go for C-reactive protein testing in primary care (MIB78)
NICE has developed a medtech innovation briefing (MIB) on the QuikRead go for C-reactive protein testing in primary care
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Infection control: prevention of healthcare-associated infection in primary and community care (CG2)
This guidance has been updated and replaced by NICE guideline CG139.
Alere Afinion CRP for C-reactive protein testing in primary care (MIB81)
NICE has developed a medtech innovation briefing (MIB) on the Alere Afinion CRP for C-reactive protein testing in primary care
NICE has developed a medtech innovation briefing (MIB) on Granulox for managing chronic non-healing wounds .
FebriDx for C-reactive protein and myxovirus resistance protein A testing (MIB224)
NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing .
Evidence-based recommendations on SEM Scanner 200 for preventing pressure ulcers.
Xpert Carba-R to identify people carrying carbapenemase-producing organisms (MIB52)
NICE has developed a medtech innovation briefing (MIB) on the Xpert Carba-R to identify people carrying carbapenemase-producing organisms
This guideline covers mental health rehabilitation for adults with complex psychosis. It aims to ensure people can have rehabilitation when they need it and promotes a positive approach to long-term recovery. It includes recommendations on organising rehabilitation services, assessment and care planning, delivering programmes and interventions, and meeting people’s physical healthcare needs.